NovaSeq X and innovations across the Illumina portfolio - AGBT Workshop
Alex Aravanis MD PhD - Chief Technology Officer, SVP, Head of Research and Product Development at Illumina - Illumina | LinkedIn
Alex Aravanis on Twitter: ".@Illumina, we know that by analyzing DNA, we can answer more questions about our health and equip the medical professionals who support and treat us to make more
Alex Aravanis MD PhD - Chief Technology Officer, SVP, Head of Research and Product Development at Illumina - Illumina | LinkedIn
Management Team
Alex Aravanis (@Alex_Aravanis) / Twitter
Alex Aravanis MD PhD - Chief Technology Officer, SVP, Head of Research and Product Development at Illumina - Illumina | LinkedIn
Illumina launches NovaSeq X Series to accelerate genomic discoveries, ET HealthWorld
A Closer Look at Illumina's Genome Sequencer 'That Will Change Everything' - Biocom California
Illumina liefert erstes NovaSeq X Plus-Sequenziergerät an das Broad Institute
Alex Aravanis MD PhD - Chief Technology Officer, SVP, Head of Research and Product Development at Illumina - Illumina | LinkedIn
Alex Aravanis | VIB Conferences
Alex Aravanis (@Alex_Aravanis) / Twitter
Alex Aravanis (@Alex_Aravanis) / Twitter
Critical-rated security flaw in Illumina DNA sequencing tech exposes patient data | TechCrunch
Management Team
Storing Growing Data While Reducing Environmental Impact
Alex Aravanis on Twitter: "Highly anticipated, unlike anything else at #AGBT23, I revealed the novel sequencing methodology behind Illumina Complete Long Reads. Land-marked technology at the single molecule scale generates highly accurate
Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via Livestream
Illumina Strikes Back: New NovaSeq X Series Sequencers to Push Boundaries on Throughput, Cost | GenomeWeb
Illumina investiert in einen 30-Millionen-Pfund-Venture-Fonds, um bahnbrechende Entwicklungen im Bereich der menschlichen Gesundheit voranzutreiben
Alex Aravanis MD PhD on LinkedIn: #agbt23 #illuminaproud #genomics #ngs #agbt23
Alex Aravanis (@Alex_Aravanis) / Twitter
Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development | Business Wire
Alex Aravanis MD PhD - Chief Technology Officer, SVP, Head of Research and Product Development at Illumina - Illumina | LinkedIn
Erstes NovaSeq X Plus-Sequenziergerät ausgeliefert - MT-Dialog
Revolutionäre NovaSeq X-Serie von Illumina: Rasche Beschleunigung genomischer Entdeckungen und Verbesserung der menschlichen Gesundheit
